Strong PSMA Expression by a Pituitary Macroadenoma on PSMA PET/CT
An 81-year-old man was found to have an elevated PSA, prompting a prostate biopsy that revealed Gleason grade 7 (3+4) prostate cancer. For staging purposes, an 18F-DCFPyL PSMA PET/CT was performed, which demonstrated focal uptake in the pituitary region corresponding to a suprasellar mass. Subsequent pituitary MRI confirmed the presence of a pituitary macroadenoma. The expanding global use of PSMA PET has increasingly revealed PSMA ligand uptake in a variety of non-prostatic benign and malignant conditions, creating false positive results. Our case highlights that pituitary macroadenoma may have strong PSMA expression and should be recognized as a potential imaging pitfall.
Authors
- Sampanna Rayamajhi (ORCID: https://orcid.org/0000-0001-8383-3216)
- Nasrin Ghesani
- Mudassir Mumtaz
- Busra Cangut (ORCID: https://orcid.org/0000-0001-6499-2123)
- Ava Mohseny
Institutions
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2025-12-19
- DOI
- https://doi.org/10.1097/rlu.0000000000006279
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00